Kepivance and fluid retention 
Kepivance and fluid retention Patient Reports February 13, 2012
Kepivance Side Effects Report #4949408-6
Kepivance side effect was reported by a Physician from GERMANY on Feb 24, 2006. Female patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: fluid retention, lung infiltration, mucosal inflammation, oedema, pneumonia
, pulmonary congestion, weight increased. Kepivance dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CASPOFUNGIN, METRONIDAZOLE, CIPROFLOXACIN, ACYCLOVIR, MORPHINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Kepivance Side Effects Report #4949410-4
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: capillary leak syndrome, fluid retention, lung infiltration, mucosal inflammation, pneumonia
, respiratory failure, weight increased. Kepivance dosage: unknown. During the same period patient was treated with FLUCONAZOLE, VALTREX, PIPERACILLIN, SANDIMMUNE. Patient was hospitalized. Patient died on 01/29/2006.Kepivance Side Effects Report #4966049-5
Kepivance side effect was reported by a Physician from GERMANY on Feb 24, 2006. Female patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: cytomegalovirus antigen positive, fluid retention, graft versus host disease, lung infiltration, mucosal inflammation, oedema, pneumonia
, pulmonary congestion, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CASPOFUNGIN, METRONIDAZOLE, CIPROFLOXACIN, ACYCLOVIR, MORPHINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Kepivance Side Effects Report #4974997-5
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, capillary leak syndrome, clostridial infection, clostridium colitis, fluid retention, lung infiltration, lung injury, mucosal inflammation, pneumonia
. Kepivance dosage: unknown. During the same period patient was treated with FLUCONAZOLE, VALTREX, PIPERACILLIN, SANDIMMUNE, CYCLOPHOSPHAMIDE, METHOTREXATE, CASPOFUNGIN. Patient was hospitalized. Patient died on 01/29/2006.Kepivance Side Effects Report #4993498-1
Kepivance side effect was reported by a Physician from GERMANY on Feb 24, 2006. Female patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: cytomegalovirus antigen positive, fluid retention, graft versus host disease, lung infiltration, mucosal inflammation, oedema, pneumonia
, pulmonary congestion, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CASPOFUNGIN, METRONIDAZOLE, CIPROFLOXACIN, ACYCLOVIR, MORPHINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Kepivance Side Effects Report #4993499-3
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, capillary leak syndrome, clostridial infection, fluid retention, lung infiltration, lung injury, mucosal inflammation, pneumonia
, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with FLUCONAZOLE, VALTREX, PIPERACILLIN, SANDIMMUNE, CYCLOPHOSPHAMIDE, METHOTREXATE, CASPOFUNGIN. Patient was hospitalized. Patient died on 01/29/2006.Kepivance Side Effects Report #4994851-2
Kepivance side effect was reported by a Physician from GERMANY on Feb 24, 2006. Female patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: cytomegalovirus antigen positive, fluid retention, graft versus host disease, lung infiltration, mucosal inflammation, oedema, pneumonia
, pulmonary congestion, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CASPOFUNGIN, METRONIDAZOLE, CIPROFLOXACIN, ACYCLOVIR, MORPHINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Kepivance Side Effects Report #4994856-1
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, capillary leak syndrome, clostridial infection, fluid retention, lung infiltration, lung injury, mucosal inflammation, pneumonia
, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with FLUCONAZOLE, VALTREX, PIPERACILLIN, SANDIMMUNE, CYCLOPHOSPHAMIDE, METHOTREXATE, CASPOFUNGIN. Patient was hospitalized. Patient died on 01/29/2006.Kepivance Side Effects Report #5019950-0
Kepivance side effect was reported by a Physician from GERMANY on Feb 24, 2006. Female patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: cytomegalovirus antigen positive, fluid retention, graft versus host disease, lung infiltration, mucosal inflammation, oedema, pneumonia
, pulmonary congestion. Kepivance dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CASPOFUNGIN, METRONIDAZOLE, CIPROFLOXACIN, ACYCLOVIR, MORPHINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Kepivance Side Effects Report #5019954-8
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, capillary leak syndrome, clostridial infection, fluid retention, lung infiltration, lung injury, mucosal inflammation, pneumonia
, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with FLUCONAZOLE, VALTREX, PIPERACILLIN, SANDIMMUNE, CYCLOPHOSPHAMIDE, METHOTREXATE, CASPOFUNGIN. Patient was hospitalized. Patient died on 01/29/2006.